Healthcare Triage: Biologic Drugs and Biosimilars

In a previous video we compared brand name and generic drugs.  But we kind of left out a major player in the world of medicines; biologic drugs. These complicated little guys probably deserve a video all to themselves.  Call them what you will -biologics, biotherapeutic medicines, or biopharmaceuticals- they’re topic of this week’s HealthCare triage.

For those of you who want to read more:

@aaronecarroll

P.S. Thanks to Rachel Hoffman, Healthcare Triage intern, for help with this episode!!!

Aaron Carroll

Aaron E. Carroll, MD, MS is co-Editor-in-Chief of The Incidental Economist and tweets at @aaronecarroll. He is the Chief Health Officer at Indiana University. He is also a Distinguished Professor of Pediatrics and Associate Dean for Research Mentoring at the Indiana University School of Medicine. In addition to contributing regularly to The New York Times and the Atlantic, he is the author of four books, most recently The Bad Food Bible.

Hidden information below

Aaron Carroll

Aaron E. Carroll, MD, MS is co-Editor-in-Chief of The Incidental Economist and tweets at @aaronecarroll. He is the Chief Health Officer at Indiana University. He is also a Distinguished Professor of Pediatrics and Associate Dean for Research Mentoring at the Indiana University School of Medicine. In addition to contributing regularly to The New York Times and the Atlantic, he is the author of four books, most recently The Bad Food Bible.

The Incidental Economist

the health services research blog

Boston-area website management by BKJ Productions
Editors In Chief
Managing Editor

Work posted here under copyright © of the authors • Details on the Site Policies page

Subscribe

Email Address*